Founded in 1963 with the vision of “scientifying Oriental medicine,” Kwangdong Pharmaceutical has contributed to public health through the development of high-quality pharmaceuticals and health beverages. Its portfolio includes well-known OTC products such as Woo Hwang Chong Shim Won and Ssangwha Tang, as well as ETC drugs including anti-cancer treatments and Korea’s first Vitamin D injection. The company has also created popular beverages like Vita 500, corn silk tea, and Jeju Samdasu distribution. Through continuous R&D investment, ERP system advancement, and strategic acquisitions, Kwangdong Pharmaceutical is strengthening its competitiveness and pursuing sustainable growth.